Oxford BioDynamics Plc (LSE: OBD) Stock Analysis & Fundamentals | ScreenerHero

Create free account

OBDOxford BioDynamics Plc

LSE · GB · Healthcare · Diagnostics & Research · oxfordbiodynamics.com

0.1300GBp+23.81%Mkt Cap: 6.06M $P/E: —1d ago

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United K…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap6.06M $

Enterprise Value7.98M $

Revenue (TTM)1.30M $

Gross Profit567.39K $

Net Income (TTM)-12.12M $

Revenue/Share0.0000 USD

Last Price0.1300 GBp

Fiscal Year EndSep 2025

MR QuarterMar 2026

Employees37

CountryGB

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.32

PEG—

EV/EBITDA-0.81

EV/Revenue6.15

P/S4.67

P/B1.30

EPS (TTM)0.00

EPS (Forward)-0.00

52W Range

0.08007% of range0.7500

52W High0.7500 GBp

52W Low0.0800 GBp

Profitability

Gross Margin47.67%

Oper. Margin-681.37%

EBITDA Margin0.00%

Profit Margin-1018.54%

ROE-999.37%

ROA-137.93%

Growth

Revenue Growth17.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF-8.23M $

CapEx (TTM)265.22K $

FCF Margin-327.47%

FCF Yield-70.15%

Net Debt1.92M $

Net Debt/EBITDA-0.19

Balance Sheet

Debt/Equity4.58

Current Ratio2.01

Quick Ratio1.89

Book Value/Sh0.0010 GBp

Cash/Share0.0010 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 GBp

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)1.000 GBp

Upside (mean)+669.2%

Target Range1.000 GBp – 1.000 GBp

# Analysts1

Ownership

Shares Out.4.29B

Float3.06B

Insiders9.87%

Institutions42.97%

Technical

SMA 500.1612 (-19.4%)

SMA 2000.2449 (-46.9%)

Beta-0.17

S&P 52W Chg20.25%

Avg Vol (30d)19.89M

Avg Vol (10d)25.05M

Technical Indicators

RSI (14)48.5

MACD-0.0172

MACD Signal-0.0195

MACD Hist.+0.0023

BB Upper0.1863 GBp

BB Middle0.1253 GBp

BB Lower0.0644 GBp

BB Width97.28%

ATR (14)0.0310 GBp

Vol Ratio (20d)1.18x